Cardiovascular & Hematological Disorders-Drug Targets
Title:Editorial [Hot Topic Proceeding for Chinese-Canada Symposium in Atherosclerosis and Cardiovascular Disease. September 23-25, Beijing, (China Guest Editor: George Liu)]
Volume: 12 Issue: 2
Author(s): George Liu, Zhisheng Jiang and Garry X. Shen
Affiliation:
Export Options
About this article
Cite this article as:
Liu George, Jiang Zhisheng and X. Shen Garry, Editorial [Hot Topic Proceeding for Chinese-Canada Symposium in Atherosclerosis and Cardiovascular Disease. September 23-25, Beijing, (China Guest Editor: George Liu)], Cardiovascular & Hematological Disorders-Drug Targets 2012; 12 (2) . https://dx.doi.org/10.2174/1871529X11202020083
DOI https://dx.doi.org/10.2174/1871529X11202020083 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resveratrol as a Gene Regulator in the Vasculature
Current Pharmaceutical Biotechnology Adverse Drug Reactions and Safety Considerations of NSAIDs: Clinical Analysis
Current Drug Safety Outcomes of Clinical Treatments Among Patients with Diabetes Mellitus in Selangor, Malaysia: A Retrospective Study
Current Diabetes Reviews Progress of Computer-Aided Drug Design (CADD) of Proteasome Inhibitors
Current Topics in Medicinal Chemistry Aliskiren in Patients with Diabetes: A Systematic Review
Current Vascular Pharmacology Should Arterial Embolization in Recurrent Spontaneous Hemoph ilic Hemarthroses Refractory to Intensive Prophylaxis be the First Invas ive Resort?
Cardiovascular & Hematological Disorders-Drug Targets Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Delineation of Current Development of Antimitotic Compounds Targeting Cytoskeletal Protein Tubulin and Microtubule in the Cancer Therapy
Current Chemical Biology Acute Management in Very Old Patients: Is Thrombolysis Safe?
Cardiovascular & Hematological Disorders-Drug Targets Rubosixtaurin and other pkc Inhibitors in Diabetic Retinopathy and Macular Edema. Review
Current Diabetes Reviews Roles of Calcium and Tyrosine Kinases in the Pathogenesis of Type 2 Diabetes Mellitus
Current Enzyme Inhibition Left Ventricular Non-compaction: From Recognition to Treatment
Current Pharmaceutical Design Epigenetics in the Cerebrovascular System: Changing the Code without Altering the Sequence
Current Neurovascular Research Cannabinoids for the Treatment of Schizophrenia: An Overview
Current Topics in Medicinal Chemistry Postprandial Glucose - A Potential Therapeutic Target to Reduce Cardiovascular Mortality
Current Vascular Pharmacology Lipid-lowering Therapy in the Diabetic Foot: Seeing the Whole Iceberg and not Just the Tip
Current Vascular Pharmacology CYP3A4 *1B Gene Polymorphism in Coronary Artery Disease Patients with Obesity Undergoing Statin Treatment
Current Pharmacogenomics and Personalized Medicine Hypertensive Pharmacogenomics in African Americans
Current Pharmacogenomics The Role of Adipokines in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Dyslipidemia Treatment and Cardiovascular Disease in the Renal Patient
Current Pharmaceutical Design